Clinical Trial Update: Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer Patients [NA]

View source ↗

Summary

The clinical trial NCT07514754 investigating Galenos 2 immunonutrition for head and neck squamous cell carcinoma, locally advanced rectal cancer, and lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Lung Cancer
• Rectal Cancer

Drugs mentioned

• Galenos 2 Immunonutrition

Snippet

Sponsor: Fondazione del Piemonte per l'Oncologia | Conditions: Head and Neck Squamous Cell Carcinoma, Locally Advanced Rectal Cancer | NA | Status: RECRUITING